STAAR Surgical (STAA)
undefined
undefined%
At close: undefined
24.86
-0.04%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye.

The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.

It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery.

In addition, the company sells injector parts, and other related instruments and devices.

It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.

The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.

STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical
STAAR Surgical logo
Country United States
IPO Date Feb 24, 1992
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 1,056
CEO Thomas G. Frinzi

Contact Details

Address:
25651 Atlantic Ocean Drive
Lake Forest, California
United States
Website https://www.staar.com

Stock Details

Ticker Symbol STAA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000718937
CUSIP Number 852312305
ISIN Number US8523123052
Employer ID 95-3797439
SIC Code 3851

Key Executives

Name Position
Thomas G. Frinzi President, Chief Executive Officer & Chairman
Dr. Keith Holliday Ph.D. Chief Technology Officer
Nancy Sabin Chief Marketing Officer
Patrick F. Williams Chief Financial Officer
Warren Foust Chief Operating Officer
Brian Moore Vice President of Investor Relations & Corporate Development
Dr. Magda Michna Ph.D. Chief Clinical, Regulatory & Medical Affairs Officer
Dr. Scott D. Barnes M.D. Chief Medical Officer
James Francese Senior Vice President of Commercial Operations - North America & APAC
Nathaniel B. Sisitsky Esq. General Counsel & Corporate Secretary

Latest SEC Filings

Date Type Title
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 31, 2024 8-K/A [Amend] Current Report
Oct 30, 2024 10-Q Quarterly Report
Oct 30, 2024 8-K Current Report
Oct 18, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Sep 06, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 19, 2024 4 Filing
Aug 07, 2024 10-Q Quarterly Report
Aug 07, 2024 8-K Current Report
Jun 24, 2024 4 Filing